[1]
Barone, C. et al. 2012. Cetuximab in first line treatment of metastatic colorectal cancer. Farmeconomia. Health economics and therapeutic pathways. 13, 1S (Jul. 2012), 1–80. DOI:https://doi.org/10.7175/fe.v13i1S.305.